<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02863315</url>
  </required_header>
  <id_info>
    <org_study_id>1604-007-752 SNUH</org_study_id>
    <nct_id>NCT02863315</nct_id>
  </id_info>
  <brief_title>The Effects of Anodal tsDCS on Chronic Neuropathic Pain After SCI</brief_title>
  <official_title>The Effects of Anodal Transcutaneous Spinal Direct Current Stimulation on Chronic Neuropathic Pain After Spinal Cord Injury: Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the analgesic effect of transcutaneous spinal direct
      current stimulation (tsDCS) applied on spinal cord in patients with spinal cord injury who
      have chronic neuropathic pain.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Twenty patients with spinal cord injury and bilateral neuropathic pain received single
      sessions of both sham and anodal tsDCS (2 mA) over tenth thoracic vertebra for 20 min
      (reference electrodes on the head vertex). Treatment order was randomly assigned. A evaluator
      rated the pain using the visual analogue scale for pain, Patient Global Assessment and
      Present Pain Intensity.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>August 2016</start_date>
  <completion_date type="Anticipated">October 2017</completion_date>
  <primary_completion_date type="Anticipated">September 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>tsDCS</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>tsDCS</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Numeric rating scale (NRS) for neuropathic pain</measure>
    <time_frame>Baseline NRS (average NRS over the preceding 24h), Change from Baseline NRS at 0, 60 and 120 minutes after the start of the stimulation</time_frame>
    <description>On a scale of 0 to 10, with 0 being no pain at all and 10 being the worst pain imaginable</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient Global Assessment (PGA)</measure>
    <time_frame>Baseline PGA (average PGA over the preceding 24h), Change from Baseline PGA at 0, 60 and 120 minutes after the start of the stimulation</time_frame>
    <description>One of the most widely used patient reported outcomes (PROs) &amp; PGA reflects the global impact of the disease from the patient's perspective
Markedly improved
Moderately improved
Mildly improved
No change
Mildly worse
Moderately worse
Markedly worse</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Present Pain Intensity (PPI)</measure>
    <time_frame>Baseline PPI (average PPI over the preceding 24h), Change from Baseline PPI at 0, 60 and 120 minutes after the start of the stimulation</time_frame>
    <description>Patient's subjective feeling of the intensity of pain right now
0: No pain
Mild
Discomforting
Distressing
Excruciating
Horrible</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Neuropathic Pain</condition>
  <condition>Spinal Cord Injury</condition>
  <arm_group>
    <arm_group_label>tsDCS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In the tsDCS group, anodal tsDCS will be applied for 20 minutes.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sham</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>In sham tsDCS group, the current of anodal tsDCS will be discontinued after 30 s while the power indicator remained on for 20 minutes.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>tsDCS</intervention_name>
    <description>Both groups use the same DC-Stimulator Plus (NeuroConn GmbH, Ilmenaus, Germany).
In the tsDCS group, anode electrode is placed over tenth thoracic vertebra to target spinal cord with 2mA for 20 min, and the cathode (reference) electrode on the head vertex (in the Cz location according to the 10-20 EEG system)
In sham tsDCS group, anode electrode is placed over tenth thoracic vertebra to target spinal cord with 2mA for 30s, and the cathode (reference) electrode on the head vertex (in the Cz location according to the 10-20 EEG system). The current was discontinued after 30 s while the power indicator remained on.</description>
    <arm_group_label>tsDCS</arm_group_label>
    <arm_group_label>sham</arm_group_label>
    <other_name>DC-Stimulator Plus (NeuroConn GmbH, Ilmenaus, Germany)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. cervical or upper thoracic complete motor spinal cord injury, at least 6 months after
             SCI, 20&lt;=age&lt;90

          2. neuropathic pain (LANSS score &gt;= 12), stable chronic pain for at least the three
             preceding months but not over 5 years

          3. score higher than or equal to 4 cm (0 cm = 'no pain' and 10 cm = 'worst possible
             pain') on the visual ana- logue scale (VAS) for pain perception at the baseline/start
             of the treatment

          4. refractoriness to drugs for pain relief - such as tricyclic antidepressants,
             antiepileptic drugs, and/or narcot- ics (pain resistant to at least two of these drugs
             supplied in ade- quate dosages for 6 months)

          5. informed consent

        Exclusion Criteria:

          1. patients with any clinically significant or unstable medical or progressive neurologic
             disorder

          2. contraindication for electrial stimulation such as pacemaker implant

          3. Women of childbearing age or pregnancy

          4. significant cognitive deficit

          5. Syringomyelia

          6. neuropsychiatric comorbidity

          7. depressive disorder (as indicated by a score of 10 greater on the Beck Depression
             Inventory)

          8. history of substance abuse

          9. skin defect under the electrodes

         10. progressive neurological disease or other secondary conditions that could impact
             neuropathic pain
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Seoul National University</name>
      <address>
        <city>Seoul</city>
        <zip>03080</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <reference>
    <citation>Ngernyam N, Jensen MP, Arayawichanon P, Auvichayapat N, Tiamkao S, Janjarasjitt S, Punjaruk W, Amatachaya A, Aree-uea B, Auvichayapat P. The effects of transcranial direct current stimulation in patients with neuropathic pain from spinal cord injury. Clin Neurophysiol. 2015 Feb;126(2):382-90. doi: 10.1016/j.clinph.2014.05.034. Epub 2014 Jun 21.</citation>
    <PMID>25027640</PMID>
  </reference>
  <reference>
    <citation>Cogiamanian F, Vergari M, Schiaffi E, Marceglia S, Ardolino G, Barbieri S, Priori A. Transcutaneous spinal cord direct current stimulation inhibits the lower limb nociceptive flexion reflex in human beings. Pain. 2011 Feb;152(2):370-5. doi: 10.1016/j.pain.2010.10.041. Epub 2010 Dec 14.</citation>
    <PMID>21159430</PMID>
  </reference>
  <reference>
    <citation>Parazzini M, Fiocchi S, Liorni I, Rossi E, Cogiamanian F, Vergari M, Priori A, Ravazzani P. Modeling the current density generated by transcutaneous spinal direct current stimulation (tsDCS). Clin Neurophysiol. 2014 Nov;125(11):2260-70. doi: 10.1016/j.clinph.2014.02.027. Epub 2014 Apr 3.</citation>
    <PMID>24784477</PMID>
  </reference>
  <reference>
    <citation>Cogiamanian F, Vergari M, Pulecchi F, Marceglia S, Priori A. Effect of spinal transcutaneous direct current stimulation on somatosensory evoked potentials in humans. Clin Neurophysiol. 2008 Nov;119(11):2636-40. doi: 10.1016/j.clinph.2008.07.249. Epub 2008 Sep 10.</citation>
    <PMID>18786856</PMID>
  </reference>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 28, 2016</study_first_submitted>
  <study_first_submitted_qc>August 7, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 11, 2016</study_first_posted>
  <last_update_submitted>April 25, 2017</last_update_submitted>
  <last_update_submitted_qc>April 25, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Hyung-ik Shin</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Cord Injuries</mesh_term>
    <mesh_term>Neuralgia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

